On October 24-25, 2022, the 7th International Conference on Pharmaceutics and Advanced Drug Delivery Systems will welcome you to Zurich, Switzerland. Pharmaceutical Science 2022 encompasses practically every aspect of knowledge, innovation, technology, and networking, with the goal of bringing academics, practitioners, and business executives together to debate the most pressing issues in pharma, biotech, and health care.
Drug Discovery and Development, Pharmacovigilance and Drug Safety, Novel Drug Delivery Systems and Drug Therapy, Pharmaceutical Nanotechnology, Drug Regulatory Affairs, Pharmacology, Neuropharmacology, Nutraceuticals, Pharma Marketing, and more are all covered in this two-day program.
Pharmaceutical Science 2022 provides unrivalled business, research, and market access prospects in the pharmaceutical and health-care industries. Be the first to learn about new and often unavailable information, and discover a field that interests you.
By participating in Pharmaceutical Science 2022, you will be able to see the rising industry and provide your career and business with new opportunities from all over the world.
WHO WILL ATTEND?
- Biotechnology experts, researchers, and scientists
- Professors and Students in Academia
- Companies in the pharmaceutical and biotechnology industries
- Departments of Healthcare
- Practitioners & Pharmacists
- Officials, decision-makers, and government heads
- R&D Labs, Policymakers, and Influencers
WHY IS THE PHARMACEUTICAL SCIENCE IMPORTANT?
- Meet the Pioneers in the Pharmaceutical and Healthcare Industries
- Translational research and evidence-based approaches should be widely disseminated.
- Investigate Future Business Prospects
- Get the latest news from hard-to-reach academic and business specialists.
- Distribute your goods and services
- Rekindle your friendships with your co-workers.
- Expect real-life examples and shared experience as a result of the case study.
Sessions and Tracks
Become a Presenter
Submit an Abstract
Start by submitting a proposal if you want to give a presentation.
The following information will be required: presentation type, short/long descriptions, keywords, focus, topics, and biographical information.
Following receipt of your presentation proposal, we will proceed to the evaluation stage. The Organizing Committee will assess all suggestions within 24 hours after their submission.
You must register before our Program Development staff can schedule your presentation once your abstract has been accepted.
Session on Pharmacogenomics
Gene testing for drugs, Personalized medicine and pharmacogenomics Challenges, Current restrictions on drug labelling Drug Sensitivity and Genetics, Costs and coverage of pharmacogenomics testing Predicting drug-drug interactions is a difficult task. Polypharmacy, Methods based on associations and expressions, Pathway-based techniques and cheminformatics Incorporation of pharmacogenomics into clinical practise Phenotyping and genotyping are two terms that are used interchangeably.
Session on Neuropharmacology
Neurotransmission in the central and peripheral nervous systems, Neurotoxicology, Growth factors for the nerves, cytoskeletal elements of the nervous system, Repairing the brain, Addiction's cellular and molecular mechanisms, Disorders of development and Neurodegeneration interactions between the brain and the immune system.
Session on Pharmacology
Clinical pharmacology, such as cardiac pharmacology and cardiovascular disease, pulmonary disease, neurodegenerative disorders, pharmacological oncology, Parkinson's disease, and circadian rhythm disorders, Molecular and Cellular Pharmacology, such as drug-receptor interactions, drug-enzyme interactions, antibiotic pharmacology, and immune responses, gene expression regulation, Pharmacogenetics, Safety Pharmacology, Toxicology, and Pharmacognosy, Environmental Pharmacology
Pharmaceutical Formulations Market, Licensing, Pharma Pricing & Market Access, Global Generic Trends & Global Pharma Market, Global Generic Trends & Global Pharma Market, Global Generic Trends & Global Pharma Market, Global Generic Trends & Global Pharma Market, Global Generic E-pharmaceutical marketing, post-market surveillance, the generic drug industry, contract manufacturing, and health economics, to name a few. Customer Lifetime Valuation, Patient-Centricity, Pharma Segmentation/Localization, Predictive Analytics, Pre-clinical Discovery, Commercial Models, Customer Lifetime Valuation, Patient-Centricity Statistical Approaches for Improving Performance and Compliance with Big Data, Architecture, Informatics, and Big Data.
Session on Digital Pharma & Multichannel Marketing
Data-Driven Health and Personalization, the Role of Artificial Intelligence in the Pharmaceutical Industry, Digital transformation on a global scale, calculating digital ROI, and analyzing digital analytics. It is critical to align innovation with company objectives. Customer Digital Habits, Channel Preferences, New Levels of Targeting, Investment Allocation, A True Learning Plan's Metrics, Marketing in a Multichannel World, Multichannel Engagement Mobilizing for Mobile Engagement, Customer Digital Habits, Channel Preferences, New Levels of Targeting, Investment Allocation, A True Learning Plan's Metrics
Session on Pharmaceutical Microbiology & Biotechnology
Pharmaceutical microbiology and animal biotechnology have evolved as a useful field for the productions of biologics from microbial cells or animal or human cell lines. Biotechnological concepts and manipulations in the these filed has enhanced the production, variety and types of biologics produced. These field are expected to grow further in the future.
Pharmaceutical and medical chemistry are interdisciplinary scientific topics that deal with drug development, molecular mechanisms of pathogenesis, pharmaceutics, pharmacology, toxicology, organic chemistry, and more. Individual investigations in both disciplines provide improved insights and understanding for the creation of novel medications and therapies.
Session on Biopharmaceutical
In the field of pharmaceutical biotechnology, recent developments have been made. Recombinant DNA Technology: Basic Techniques and Tools, Vectors, Cloning Strategies, and Host Systems Genetic engineering has been used to make recombinant therapeutic proteins, vaccines, recombinant blood products and therapeutic enzymes, as well as nucleic acid and cell-based medicines.
Session on Pharmaceutical Nanotechnology
Pharmaceutical nanotechnology provides innovative tools and technology, as well as opportunities and scope, in many areas of the healthcare industry, and it is now well-established as a specialized area for drug delivery, diagnostics, prognostics, and various treatment procedures, thanks to its nano-engineered tools and techniques. By overcoming the constraints of present technology in the pharmaceutical sector, it will have a significant impact in the future.
Session on Pharmacovigilance & Drug Safety
In the field of drug regulation, pharmacovigilance is a term that is used to describe the monitoring of Trials in Medicine, Clinical safety prior to marketing, Safety of drugs once they've been released, Strategies for risk management, Data mining and signal detection Drug interaction detection, Harmonization of drug regulatory requirements on a global scale, Management of risks and crises Traditional and Herbal Medicines, Vaccines and biological medicines are two examples of vaccines.
Session on Drug Discovery & Development
Drug discovery and development in its entirety, encompassing genomics and proteomics research, applications, technologies, and tactics to speed up the pace and productivity of drug development. Pharmacotherapy, Clinical trials, Case studies in a variety of therapeutic and disease domains, translational medicine, translational and preclinical models
Session on Clinical Trials & Drug Regulatory Affairs
Recent advancements in research, Clinical trials, patient-centered clinical trial techniques, Preclinical Research Innovations, Medical Imaging, Clinical Trial Participation Multi-arm multi-stage (MAMS) trials, Pharmacodynamics, Screening, Ethical aspects, Patient safety, International Regulatory Affairs, Quality assurance, Biosimilars Licensing and authorization are required. Regulatory Affairs, Regulatory and Post-Marketing Issues: International Guidelines
Session on Challenges in Drug Delivery
This session addresses important issues in drug delivery systems such as poorly soluble drug component distribution and bioavailability, as well as drug molecules' inaccessibility to the target location. Biologics (peptides, proteins, and DNA-based therapies) drug delivery, as well as pediatric and geriatric medication delivery, are all major challenges. Despite the fact that various tactics and procedures have been created to address drug delivery issues, they have some flaws. Such barriers in drug delivery systems can be overcome with the help of innovative technology.
Sessions on Advances in Drug Delivery Research
To tackle the problems of drug delivery, new technologies and methodologies are being developed. Smart drug delivery systems, sustained release drug delivery systems, nano particle-based drug delivery systems, medical devices for drug delivery, biologics drug delivery systems, and printing technology in dosage forms are among them. Drug delivery systems (DDS) are a group of novel methodologies that combine pharmaceutics, bio conjugate chemistry, molecular biology, pharmacology, polymer sciences, nanotechnology, and electronics in a multidisciplinary approach. A successful drug delivery system is essential for effective disease therapy.
Session on Nanotechnology & Drug Carrier Systems
Nanotechnology, polymer science, and biomaterial sciences all have a lot of potential and opportunity for developing innovative medication delivery techniques and systems.
Session on Novel Drug Delivery System
Recent therapeutic application and formulation system development efforts to boost medication delivery potential, Drug Delivery Carrier, Nanoparticles, Mucoadhesive Drug Delivery System, Novel Drug Delivery System and Market Opportunities, Drug Delivery Biomaterials, Routes of Administration, Future Opportunities and Challenges, Drug Therapy
Session on Alternative Drug Delivery System
The most often utilized drug delivery systems are the oral and parenteral drug administration systems. Alternative drug delivery mechanisms such as pulmonary drug delivery, transdermal drug delivery, prodrug delivery, ocular drug delivery, and transmucosal drug delivery will be discussed in this session.
Session on Peptides & Protein Drug Delivery
The obstacles of delivering protein-based treatments have grown dramatically since the development of peptide and protein medicines. This session will cover issues in various types and routes of peptide and protein drug delivery, vaccine design and drug delivery, recent advances in protein-based drug delivery, and solutions to overcome drug delivery-related constraints.
Session on Neutraceuticals
Disease Prevention and Treatment using Nutraceuticals, Probiotics and Prebiotics, Nutraceuticals for Weight Management, Dietary Supplements & Functional Foods, Personalized Nutrition and Medicine Probiotics and prebiotics, Skincare Supplements and Cosmetics, Nutraceuticals Markets-Growth Trends, Nutraceuticals Markets-Growth Trends, Nutraceuticals Markets-Growth Trends, Nutraceuticals Markets-Growth Trends, Nutraceuticals Markets-Growth Trends.
Session on Analytical & Bioanalyitical Techniques
Spectroscopic Techniques, Mass Spectrometry in Bioanalysis, Mass Spectrometry Method Development and Validation, HPLC Method Development and Validation, Analytical Techniques, Mass Spectrometry Method Development and Validation Qualitative Analytical Techniques, Qualitative Analysis, Advances in Sample Preparation for Bioanalytical Techniques
Session on Cosmeceuticals
Cosmetics' Function, Cosmetics' biological impacts, a framework for regulation How do cosmetics vary from pharmaceuticals? Product Evaluation, Cosmetics and Microbiological Safety, Hair and Skin Care, Packaging, efficacy and safety Processes for anti-aging and tissue repair Biotech product development opportunities and challenges Cosmetics and the marketplace, the interface and interaction between food and cosmetics, Animal Experiments, Microbeads made of plastic, Endocrine disruptors, endocrine disruptors, endocrine disruptor Products that are fakes
Prescription pharmaceuticals, vaccinations, and over-the-counter (OTC) drugs are all generated based on discoveries from life sciences research, which has a direct impact on the pharmaceutical industry. The pharmaceutical landscape has changed dramatically as a result of the advent of new technology and more efficient manufacturing methods. Drug development has been greatly facilitated by emerging technology, which has allowed the process to become more exact and accurate. Artificial intelligence systems are being employed more and more in disease diagnosis and treatment planning, and this trend is expected to continue in the coming years.
The global drug discovery services market is predicted to increase at a CAGR of 14.3 percent between 2021 and 2026, from USD 16.1 billion in 2021 to USD 31.4 billion in 2026. To improve drug candidate identification, new technologies such as high throughput, bioinformatics, and combinatorial chemistry are being used more frequently. The emergence of new and re-emerging infectious diseases, increased industry initiatives to improve vaccine R&D, expanding government support for vaccine development, and a greater focus on immunization are all driving market growth.
The global vaccination market (including COVID-19 vaccines) is predicted to reach USD 149.2 billion by 2026, up from USD 139.4 billion in 2021, throughout the projection period. Increased adoption of higher-value vaccine packaging technologies with improved barrier, safety, and ease-of-use qualities, as well as the expansion and upgrading of preventative medicine activities, will help to raise gains.
To combat the COVID-19 pandemic, countries' health systems are actively investing in research and development. Potential chemicals were found in CHEMBL, ZINC, FDA-approved medications, and molecules in clinical studies. COVID-19 medications are being developed by evaluating both new and existing pharmaceuticals for their ability to alleviate symptoms and inhibit viral replication. The urge to produce a cure for COVID-19 as a result of the pandemic is expected to boost the drug discovery market.